{"log_id": 1273884989418827112, "direction": 0, "words_result_num": 29, "words_result": [{"probability": {"variance": 0.00091, "average": 0.980913, "min": 0.928667}, "location": {"width": 84, "top": 245, "height": 25, "left": 234}, "words": "1、警告"}, {"probability": {"variance": 1.1e-05, "average": 0.998187, "min": 0.983673}, "location": {"width": 901, "top": 282, "height": 40, "left": 295}, "words": "急性磷酸钠盐肾病和肾功能损害:服用本品可能引起罕见但严重的急性磷酸钠盐肾病和肾功能"}, {"probability": {"variance": 5e-06, "average": 0.998488, "min": 0.990888}, "location": {"width": 962, "top": 332, "height": 41, "left": 233}, "words": "损害。据报道,患者在内镜检查前和术前使用磷酸钠盐制剂清洗肠道可能发生肾损害和急性磷酸钠"}, {"probability": {"variance": 1e-06, "average": 0.999268, "min": 0.996187}, "location": {"width": 961, "top": 382, "height": 39, "left": 233}, "words": "盐肾病(即肾钙质沉着),并导致短暂或永久性肾功能损害(肾功能衰竭),部分患者需要进行透析"}, {"probability": {"variance": 0.003183, "average": 0.989386, "min": 0.620459}, "location": {"width": 960, "top": 431, "height": 40, "left": 235}, "words": "和/或移植。上述不良反应多数发生在服用高血压药物(如血管紧张素转换酶抑制剂、血管紧张素受"}, {"probability": {"variance": 8e-06, "average": 0.99821, "min": 0.986529}, "location": {"width": 963, "top": 481, "height": 41, "left": 234}, "words": "体抑制剂)或利尿剂、非甾体抗炎药的患者当中。建议肾功能损害、正在接受可能引起肾小管滤过"}, {"probability": {"variance": 6e-06, "average": 0.998537, "min": 0.987787}, "location": {"width": 961, "top": 531, "height": 40, "left": 234}, "words": "率下降的治疗或可能导致脱水的治疗(如利尿剂、血管紧张素转换酶抑制剂、血管紧张素受体抑制"}, {"probability": {"variance": 3.5e-05, "average": 0.996846, "min": 0.971264}, "location": {"width": 933, "top": 582, "height": 39, "left": 235}, "words": "剂、非甾体抗炎药)的高风险患者应慎用本品,此类患者应在做通便准备和适当处理前补足水分"}, {"probability": {"variance": 0.000734, "average": 0.993591, "min": 0.825541}, "location": {"width": 903, "top": 632, "height": 37, "left": 280}, "words": "惊厥:据报道,先前无惊厥病史的患者使用磷酸钠盐后可能发生罕见的阵发性痉挛和意识丧失"}, {"probability": {"variance": 0.002233, "average": 0.984111, "min": 0.776905}, "location": {"width": 966, "top": 680, "height": 42, "left": 231}, "words": "惊厥与电解质紊乱和血浆低渗透压有关。建议本品慎用于易于发生惊厥的高风险患者,如有惊厥病"}, {"probability": {"variance": 0.014107, "average": 0.958392, "min": 0.445372}, "location": {"width": 720, "top": 719, "height": 48, "left": 233}, "words": "史、合并使用抗抑郁药物、戒断酒精及苯二氮类药物、低钠血症患者。"}, {"probability": {"variance": 1.2e-05, "average": 0.998096, "min": 0.979269}, "location": {"width": 903, "top": 780, "height": 38, "left": 281}, "words": "心律失常:据报道,患者使用磷酸钠盐后可能发生严重和罕见的心律失常和部分QT间期延长"}, {"probability": {"variance": 0.000116, "average": 0.995372, "min": 0.937191}, "location": {"width": 962, "top": 829, "height": 38, "left": 233}, "words": "QT间期延长与电解质紊乱有关(如低钾和低钠血症)。建议本品慎用于易于发生心律失常的高风险"}, {"probability": {"variance": 2.7e-05, "average": 0.997439, "min": 0.977354}, "location": {"width": 961, "top": 877, "height": 39, "left": 233}, "words": "患者,如有心肌病和难以控制心率失常病史、QT间期延长、近期发生心梗的患者。此类患者用药时"}, {"probability": {"variance": 1.2e-05, "average": 0.99799, "min": 0.985472}, "location": {"width": 478, "top": 932, "height": 32, "left": 233}, "words": "建议在用药前和检查后使用心电图全程密切监测"}, {"probability": {"variance": 2e-05, "average": 0.997767, "min": 0.982838}, "location": {"width": 290, "top": 983, "height": 28, "left": 233}, "words": "2、上市前和上市后不良反应"}, {"probability": {"variance": 1.3e-05, "average": 0.998083, "min": 0.982158}, "location": {"width": 901, "top": 1025, "height": 37, "left": 281}, "words": "通过上市前临床试验观察,服用磷酸钠盐制剂或本品最常见的不良反应(≥2%)为腹胀、恶心"}, {"probability": {"variance": 0.001479, "average": 0.988877, "min": 0.773544}, "location": {"width": 950, "top": 1075, "height": 36, "left": 233}, "words": "腹痛、呕吐,还可能会出现用药期间和用药后的短暂的电解质紊乱(高/低磷酸钠盐血症、低钙血症"}, {"probability": {"variance": 0.000122, "average": 0.995773, "min": 0.926599}, "location": {"width": 951, "top": 1124, "height": 36, "left": 233}, "words": "低钾血症、高钙血症和脱水)、乏力、眩晕、过敏反应、肝功能检查ALT、AST升高、肛门刺激症状"}, {"probability": {"variance": 2.1e-05, "average": 0.996675, "min": 0.988717}, "location": {"width": 94, "top": 1182, "height": 25, "left": 233}, "words": "偶见流涎"}, {"probability": {"variance": 8.7e-05, "average": 0.996665, "min": 0.943816}, "location": {"width": 915, "top": 1222, "height": 36, "left": 283}, "words": "上市后报告中还发现变态反应(皮疹、紫癜水肿和口唇感觉异常等)、急性磷酸盐肾病、肾功"}, {"probability": {"variance": 3.3e-05, "average": 0.996897, "min": 0.983031}, "location": {"width": 255, "top": 1279, "height": 28, "left": 233}, "words": "能衰竭、惊厥、心律失常"}, {"probability": {"variance": 0, "average": 0.99967, "min": 0.999141}, "location": {"width": 81, "top": 1328, "height": 26, "left": 240}, "words": "【禁忌】"}, {"probability": {"variance": 0.003546, "average": 0.980747, "min": 0.67235}, "location": {"width": 736, "top": 1370, "height": 35, "left": 315}, "words": "本品禁用于先天性巨结肠、肠梗阻、腹水、充血性心脏病或肾功能衰竭患者"}, {"probability": {"variance": 2.1e-05, "average": 0.997042, "min": 0.981306}, "location": {"width": 400, "top": 1423, "height": 30, "left": 279}, "words": "2、使用本品禁止联合使用其他缓泻药物"}, {"probability": {"variance": 0.000795, "average": 0.985705, "min": 0.889931}, "location": {"width": 421, "top": 1471, "height": 32, "left": 279}, "words": "3、对本品磷酸钠盐和其他成分过敏者禁用"}, {"probability": {"variance": 2e-06, "average": 0.998817, "min": 0.995981}, "location": {"width": 125, "top": 1523, "height": 27, "left": 240}, "words": "注意事项】"}, {"probability": {"variance": 0.010571, "average": 0.974658, "min": 0.377639}, "location": {"width": 790, "top": 1563, "height": 35, "left": 316}, "words": "严格控制本品使用剂量在24小时内使用超过推荐的剂量可能会对身体造成损害"}, {"probability": {"variance": 0.000305, "average": 0.993378, "min": 0.902826}, "location": {"width": 772, "top": 1612, "height": 35, "left": 279}, "words": "2、本品若重复给药,应检查血浆电解质。在患者第二次摄入药物前应充分饮水"}], "language": 3}